MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-05-0001017
Swift Life Sciences Private Limited
Swift Life Sciences Private Limited - pharma in Dehradun, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹68.84 Cr
▲ 109% YoY
Net profit · FY 2025
₹96.63 Lakh
Net margin 1.4%
EBITDA · FY 2025
₹3.27 Cr
EBITDA margin 4.8%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹4 Cr
Issued & subscribed
Open charges
₹26.05 Cr
Satisfied ₹15.12 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
11
Provident fund records
About Swift Life Sciences Private Limited
Data last updated:
Swift Life Sciences Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U85100UR2009PTC001844. Its GSTIN is 05AANCS5518H1Z6 (Uttarakhand).
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹4 Cr. It is led by directors Ganesh Kumar Tripathi and Devesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 1 Sara Industrial Estate Rampur Selaqui Dehradun, Uttarakhand, India – 248197.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.84 Cr, a growth of 109% compared to the previous year. For the same year it recorded a net profit of ₹96.63 Lakh (net margin 1.4%) and EBITDA of ₹3.27 Cr (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 93% over three years and 109% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹26.05 Cr and satisfied charges of ₹15.12 Cr on record. Court records list 6 cases involving the company, including 1 filed by the company and 5 filed against it; 1 case is pending. The company has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹7.49 Cr; the latest was in March 2025. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Sanjivani Biochem Private Limited with revenue of ₹69.17 Cr.
Swift Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0001017). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Swift Life Sciences Private Limited
CIN U85100UR2009PTC001844
Registration Number 001844
Incorporation Date 13 November 2009
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-05-0001017
CIN History of Swift Life Sciences Private Limited
Swift Life Sciences has one previous CIN (Corporate Identification Number): U85100WB2009PTC139362. The current CIN is U85100UR2009PTC001844, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100UR2009PTC001844 | Current |
| U85100WB2009PTC139362 | Previous |
Recognitions & Rankings of Swift Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 1 Sara Industrial Estate Rampur Selaqui Dehradun, Uttarakhand, India – 248197
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Swift Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Swift Life Sciences Private Limited
The main business activity of Swift Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Swift Life Sciences Private Limited FY 2025 filings available
Swift Life Sciences Private Limited reported revenue of ₹68.84 Cr (up 109% YoY) for FY 2025.
Revenue · FY 2025
₹68.84 Cr ▲ 109%
Net profit · FY 2025
₹96.63 Lakh margin 1.4%
EBITDA · FY 2025
₹3.27 Cr margin 4.8%
Compounded Annual Growth Rate (CAGR) of Swift Life Sciences Private Limited
Revenue CAGR growth
1 year
▲ 109%
3 years · compounded
▲ 93%
5 years · compounded
▲ 109%
EBITDA CAGR growth
1 year
▲ 118%
3 years · compounded
▲ 45%
Revenue has grown at a compounded annual rate (CAGR) of 109% over five years, including 109% growth in the latest year. EBITDA rose 118% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Swift Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.27 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹96.63 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Swift Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Swift Life Sciences are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Swift Life Sciences Private Limited
Swift Life Sciences has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganesh Kumar Tripathi | Director | 24 Feb 2020 | 6 Years 7 Months | Current |
| Devesh Kumar Also directs: Pinakihuman Care E-Commerce Private Limited | Director | 27 May 2022 | 4 Years 4 Months | Current |
Peer Comparison of Swift Life Sciences Private Limited
Swift Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanjivani Biochem Private Limited | ₹69.17 Cr (FY 2025) | •••• | •••• | 64.0% | •••• | Ahmedabad, Gujarat, India |
| Zelleven Lifescience Private Limited | ₹69.02 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Three B Healthcare Limited | ₹68.95 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Vama Lifecare Private Limited | ₹68.87 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Sunglow Lifescience Private Limited | ₹68.84 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Chennai, Tamil Nadu, India |
| Swift Life Sciences Private Limited this company | ₹68.84 Cr (FY 2025) | •••• | •••• | 109.0% | •••• | Dehradun, Uttarakhand, India |
| Pristine Pearl Pharma Private Limited | ₹68.51 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Ukkadam, Tamil Nadu, India |
| Merit Organics Limited | ₹68.45 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Mumbai, Maharashtra, India |
| Super Lifecare Private Limited | ₹68.31 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Ahmedabad, Gujarat, India |
| Oxford Laboratories Private Limited | ₹67.77 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Mumbai, Maharashtra, India |
| Beloorbayir Biotech Limited | ₹67.42 Cr (FY 2021) | •••• | •••• | -4.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Swift Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Swift Life Sciences Private Limited
Swift Life Sciences Private Limited is audited by R.LAHIRI & CO for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R.LAHIRI & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Swift Life Sciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Swift Life Sciences Private Limited
Open charges
₹26.05 Cr
Satisfied charges
₹15.12 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2026 | Sidbi | ₹2.14 Cr | Open |
| 18 Aug 2025 | Axis Bank Limited | ₹21 Cr | Open |
| 28 Apr 2023 | Others | ₹15.97 Lakh | Open |
| 19 Jun 2018 | Others | ₹2.75 Cr | Open |
| 06 Feb 2025 | Bank of India | ₹1.5 Cr | Satisfied |
Total charge records: 8 View all charges
Deals & Funding of Swift Life Sciences Private Limited
Swift Life Sciences Private Limited has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹7.49 Cr; the latest was in March 2025.
Total deals
8
Secondary share transfers
6
Funding rounds
2
Disclosed funding
₹7.49 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Mar 2025 | Funding round | ₹3.84 Cr | Investors: Vijay Kumar Kanoria Huf, 3 individuals |
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Chemick Organics Private Limited , Med Biogenex Private Limited |
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: Chemick Organics Private Limited , an individual Seller: Raj Kamal Kanoria Huf, Macro Distributors Private Limited , Vijay Kumar Kanoria Huf, an individual |
| Mar 2017 | Funding round | ₹3.65 Cr | Investors: 4 individuals |
Premium access
Full deal history
All 8 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Swift Life Sciences Private Limited
Swift Life Sciences Private Limited has 6 court cases on record: 1 filed by Swift Life Sciences, 5 filed against it. 1 case is pending and 5 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
6
Filed by the company
1
Filed against the company
5
Pending
1
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 2 | 0 |
| District courts | 3 | 3 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (CRR) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharma Laboratories Limited | Disposed |
| District court, Ananthapur, Andhra Pradesh | Court case (PRC) | Filed against the company by State of Andhra Pradesh | Pending |
| District court, SAS Nagar, Punjab | Criminal miscellaneous application | Filed against the company by State of Punjab ( | Disposed |
| District court, Amritsar, Punjab | Criminal miscellaneous application | Filed against the company by State | Disposed |
Premium access
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Swift Life Sciences Private Limited
Swift Life Sciences Private Limited has a workforce of 11 employees as of Oct 11, 2025.
Employee count
11
Active EPFO establishments
1
Employee growth
37.5%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Swift Life Sciences Private Limited
Swift Life Sciences Private Limited has 14 board changes on record since 2012: 2 appointments and 12 cessations. The latest: Utpal Das ceased to be Director on 03 May 2024.
Charges
A charge with Sidbi amounted to Rs. 2.14 Cr with Charge ID 101228652 was registered on 15 Jan 2026.
AGM
Swift Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 21.00 Cr with Charge ID 101144016 was registered on 18 Aug 2025.
Charges
A charge registered on 03 Jun 2024 via Charge ID 100955002 with Bank Of India was fully satisfied on 01 Aug 2025.
Charges
A charge registered on 20 Jan 2017 via Charge ID 100586929 with Others was fully satisfied on 09 Jun 2025.
Charges
A charge registered on 06 Feb 2025 via Charge ID 101046741 with Bank Of India was fully satisfied on 04 Apr 2025.
Filing
Swift Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Charges
A charge with Bank Of India of Rs. 12.74 Cr registered on 03 Jun 2024 with Charge ID 100955002 was modified on 19 Mar 2025.
Charges
A charge with Others of Rs. 0.50 Cr registered on 20 Jan 2017 with Charge ID 100586929 was modified on 25 Feb 2025.
Charges
A charge with Bank Of India amounted to Rs. 1.50 Cr with Charge ID 101046741 was registered on 06 Feb 2025.
Charges
A charge with Bank Of India amounted to Rs. 12.74 Cr with Charge ID 100955002 was registered on 03 Jun 2024.
Charges
A charge registered on 11 Aug 2020 via Charge ID 100365385 with Others was fully satisfied on 14 May 2024.
19 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Swift Life Sciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Swift Life Sciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Swift Life Sciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Swift Life Sciences Private Limited
Swift Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AANCS5518H1Z6 | Uttarakhand | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Swift Life Sciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swift Life Sciences Private Limited
Swift Life Sciences is an active private limited company based in Dehradun, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 November 2009 (17+ years old) and is registered under CIN U85100UR2009PTC001844.
Swift Life Sciences reported revenue of ₹68.84 Cr for FY 2025 (up 109% YoY).
Swift Life Sciences has 2 current directors:
- Ganesh Kumar Tripathi - Director
- Devesh Kumar - Director
Swift Life Sciences reported a net profit of ₹96.63 Lakh (net margin 1.4%) and EBITDA of ₹3.27 Cr (EBITDA margin 4.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Swift Life Sciences is 93% over three years and 109% over five years. In the latest year (FY 2025) revenue rose 109%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Swift Life Sciences is 05AANCS5518H1Z6, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Swift Life Sciences is U85100UR2009PTC001844. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swift Life Sciences has 6 court cases on record: 1 filed by the company and 5 filed against it. 1 is pending. Most are in the high courts.
Swift Life Sciences was incorporated on 13 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Uttarakhand.
Swift Life Sciences has 8 deals on record (6 secondary share transfers, 2 funding rounds), with disclosed funding of ₹7.49 Cr; the latest was in March 2025.
The peers of Swift Life Sciences by revenue are Sanjivani Biochem Private Limited, Zelleven Lifescience Private Limited, Three B Healthcare Limited, Vama Lifecare Private Limited, Sunglow Lifescience Private Limited and 5 more, all in the Pharma industry (Formulations).